🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10245+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10245 recruiting trials

Phase 4RecruitingNCT05213676

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

👨‍⚕️ Matthew Harting, MD, MS, FACS, The University of Texas Health Science Center, Houston📍 19 sites📅 Started Nov 2025View details ↗
NARecruitingNCT07540260

CAIX PET/ CT Guided Radiation Therapy in CcRCC.

🏥 Peking University First Hospital📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT06585358

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

👨‍⚕️ Lina Davies Forsman, MD, PhD, Karolinska Institutet📍 2 sites📅 Started Nov 2025View details ↗
Phase 2Enrolling by InvitationNCT07312578

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy(nCT) in the Treatment of Esophageal Squamous Cell Carcinoma

👨‍⚕️ Zhihao MM Lu, PHD, Peking University Cancer Hospital & Institute📍 1 site📅 Started Nov 2025View details ↗
Phase 1Enrolling by InvitationNCT07228702

Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

🏥 Vancouver Coastal Health📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT07377058

RCT of Tocilizumab for Anti-MDA5+DM

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Nov 2025View details ↗
Enrolling by InvitationNCT07435116

Duchenne Muscular Dystrophy and the Viscoelastic Properties of Upper Limb Muscles

🏥 Sanko University📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07213297

Comprehensive Program for Hereditary Transthyretin Amyloidosis

🏥 Hospital de Alta Complejidad en Red📍 1 site📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT07413809

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

👨‍⚕️ Peipei Ye, The Affiliated People's Hospital of Ningbo University📍 1 site📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT07487077

Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya

🏥 Albert B. Sabin Vaccine Institute📍 1 site📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07208591

To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

👨‍⚕️ Bin M.D. Cao, China-Japan Friendship Hospital📍 15 sites📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07304284

Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus

👨‍⚕️ Tarun Saluja, MD, International Vaccine Institute📍 5 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07123155

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

🏥 Shionogi📍 28 sites📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT06840496

To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

👨‍⚕️ Lloyd L Tran, PhD, Biomed Industries, Inc.📍 20 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06851559

A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

👨‍⚕️ Medical Director, Phathom Pharmaceuticals📍 39 sites📅 Started Oct 2025View details ↗
RecruitingNCT07185919

A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

👨‍⚕️ Ipsen Medical Director, Ipsen📍 2 sites📅 Started Oct 2025View details ↗
Enrolling by InvitationNCT07449949

A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma

🏥 Eye & ENT Hospital of Fudan University📍 1 site📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07026474

Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC

🏥 Universität des Saarlandes📍 18 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07192068

Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.

👨‍⚕️ Barbara PISTILLI, Dr, Gustave Roussy, VILLEJUIF📍 4 sites📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07182149

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

👨‍⚕️ Viviana Bozon, MD, Normunity AccelCo, Inc.📍 9 sites📅 Started Oct 2025View details ↗
← PreviousPage 50 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →